Mark T Wakabayashi, Phyllis Zee, M Alma Rodriguez, Mindy Goldman, Tracey O'Connor, Divya Koura, Tara Sanft, Amye Tevaarwerk, Michelle Melisko, Melissa Hudson, Deborah A Freedman-Cass, Jose G Montoya, Crystal S Denlinger, Paula Silverman, Kathi Mooney, Shrujal Baxi, Elizabeth Kvale, Allison King, Debra L Friedman, Nicole R McMillian, Sophia Smith, Susan G Urba, K Scott Baker, Karen L Syrjala, Wendy Demark-Wahnefried, Gregory Broderick, Robin M Lally, Kathryn J Ruddy, Jeffrey Peppercorn, Electra D Paskett, Linda Overholser, Javid J Moslehi, Terry S Langbaum, Nazanin Khakpour
Many cancer survivors experience menopausal symptoms, including female survivors taking aromatase inhibitors or with a history of oophorectomy or chemotherapy, and male survivors who received or are receiving androgen-ablative therapies. Sexual dysfunction is also common in cancer survivors. Sexual dysfunction and menopause-related symptoms can increase distress and have a significant negative impact on quality of life. This portion of the NCCN Guidelines for Survivorship provide recommendations for screening, evaluation, and treatment of sexual dysfunction and menopausal symptoms to help healthcare professionals who work with survivors of adult-onset cancer in the posttreatment period.